Profile
Hartmut J.
Ehrlich is currently the Chief Executive Officer at Wittycell SAS and Director at Spikimm SAS.
Previously, he was the Chief Executive Officer at Abivax SA from 2013 to 2023 and Head-Global Research & Development at Baxter International, Inc. from 2006 to 2013.
Hartmut Ehrlich active positions
| Companies | Position | Start |
|---|---|---|
Wittycell SAS
 Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Chief Executive Officer | - |
| Spikimm SAS | Director/Board Member | - |
Former positions of Hartmut Ehrlich
| Companies | Position | End |
|---|---|---|
| ABIVAX | Chief Executive Officer | 2023-05-04 |
| BAXTER INTERNATIONAL INC. | Chief Tech/Sci/R&D Officer | 2013-08-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| ABIVAX | Health Technology |
| Private companies | 2 |
|---|---|
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Health Technology |
| Spikimm SAS |
- Stock Market
- Insiders
- Hartmut Ehrlich
